Chewable, dissolving and liquid ED products: which are FDA-approved

Status: Compounded: not FDA-approved (applies to compounded chewables, troches, mints and gummies). Source: FDA, Compounding and the FDA: Questions and Answers, and Drugs@FDA, checked 2026-10-17.

In short: most ED medicines are swallowed tablets, but a few FDA-approved forms melt on the tongue instead. We searched FDA’s Drugs@FDA records on 2026-10-17 for every product containing sildenafil, tadalafil, vardenafil or avanafil, the four ED medicines in the PDE5 inhibitor class. The approved non-tablet forms for ED come down to a dissolving vardenafil tablet, a sildenafil oral film, and a chewable tadalafil that was approved but never sold. No gummy, mint, troche or lozenge of any of these drugs appears in FDA’s approval records.

Sources: vardenafil ODT label, DailyMed; Vybrique label, DailyMed; Drugs@FDA records for Vybrique, Staxyn and Chewtadzy; the Federal Register notice on Chewtadzy; Tadliq label; sildenafil oral suspension label; FDA, Compounding Q&A; FDA, tainted honey-based products.

Is there an FDA-approved dissolving ED tablet?

Yes. Vardenafil orally disintegrating tablets (ODT) are FDA-approved to treat erectile dysfunction, and the label says the tablet “should be placed on the tongue where it will disintegrate” and “should be taken without liquid” (vardenafil ODT label, Alembic, DailyMed). The label shown here is a generic approved under ANDA208324. The original brand, Staxyn, was approved in 2010 and is now listed as discontinued, with FDA noting it was not withdrawn for safety or effectiveness reasons (Drugs@FDA, Staxyn).

The dissolving tablet is not just a regular tablet that melts. Its label says it “provides higher systemic exposure” than the film-coated vardenafil tablet and that the two are “not interchangeable” (vardenafil ODT label). How you take it changes how much reaches the blood: the label reports that when the tablet was swallowed with water, total exposure (AUC) fell by 29%. That is why switching between forms is a prescriber’s decision, not a swap at home. Our vardenafil vs sildenafil comparison covers how vardenafil differs from the better-known pill.

Is there a sildenafil that dissolves on the tongue?

Yes, since late 2025. Vybrique is a sildenafil oral film, and its label lists it as a prescription medicine “used to treat erectile dysfunction (ED)” (Vybrique label, IBSA, DailyMed). FDA approved it as a new dosage form on December 16, 2025, under NDA210858 (Drugs@FDA, Vybrique). The label says to place the film on the tongue, where it disintegrates and can be swallowed with saliva without water, and not to cut or chew it.

The active drug is still sildenafil, the same ingredient as Viagra, so the same warnings apply. Vybrique’s label lists the usual contraindications: nitrates in any form, the lung medicine riociguat, and allergy to sildenafil or the film’s ingredients. Our page on whether sildenafil is the same as Viagra explains how brand names and the molecule relate.

Is there an FDA-approved chewable ED medication?

There is one on paper, but you will not find it at a pharmacy. Chewtadzy, a chewable tadalafil tablet, was approved on June 28, 2024, for erectile dysfunction, for the urinary symptoms of an enlarged prostate (benign prostatic hyperplasia), and for both together (Federal Register, April 16, 2026). According to the same notice, the company “has never marketed” it, so FDA lists it in the discontinued section of the Orange Book.

FDA also determined that Chewtadzy was not withdrawn for reasons of safety or effectiveness. That determination lets FDA approve generic chewable tadalafil that refers to it, if a company applies and meets the legal requirements (same source). When we searched Drugs@FDA on 2026-10-17, Chewtadzy was the only chewable tadalafil application on record. So a “chewable tadalafil” offered for sale today is very likely compounded, not an approved product. Our page on generic Cialis covers the approved tablet generics and how to tell them from compounded tadalafil.

Is there a liquid ED medication?

No liquid form of any PDE5 inhibitor is FDA-approved for ED. Liquid sildenafil and liquid tadalafil do exist as FDA-approved prescription medicines, but only for pulmonary arterial hypertension, a form of high blood pressure in the lungs. The tadalafil oral suspension Tadliq is indicated “for the treatment of pulmonary arterial hypertension” (Tadliq label, DailyMed), and generic sildenafil oral suspension carries the same lung-disease indication (sildenafil oral suspension label, DailyMed).

Both labels warn against doubling up. The Tadliq label tells patients not to take Cialis or other ED medicines during treatment, and the sildenafil suspension label says patients should not take Viagra or other PDE5 inhibitors. A liquid sold for ED is therefore not an FDA-approved ED product. Our page on combining ED medications explains why two PDE5 inhibitors together is a known risk.

Are troches, mints and gummies FDA-approved?

No. FDA’s approval records for sildenafil, tadalafil, vardenafil and avanafil list tablets, the dissolving forms above, the never-marketed chewable, the lung-disease liquids, and a capsule combining tadalafil with finasteride that is approved for an enlarged prostate, not ED (Drugs@FDA; Entadfi label). No troche, mint, lozenge or gummy appears (Drugs@FDA, searched 2026-10-17). A troche, mint, lozenge, gummy or “rapid-dissolve tablet” containing one of these drugs therefore falls into one of two groups. Either it was compounded, or it was sold outside the legal system.

The second group has a track record. FDA has sent warning letters to four companies selling honey-based products and published public notifications on 24 honey-based products, after its lab testing found tadalafil or sildenafil that was not listed on the labels (FDA, tainted honey-based products). FDA warns that these hidden ingredients “may interact with nitrates” in some prescription drugs and “may lower blood pressure to dangerous levels” (same source). Our running summary of FDA tainted supplement warnings collects these notices.

What does compounded mean?

A compounded drug is made by a licensed pharmacist, a physician, or an outsourcing facility rather than being an FDA-approved product; FDA describes compounding as creating a medication tailored to the needs of an individual patient. FDA’s own wording is blunt: “Compounded drugs are not FDA-approved,” which means FDA “does not verify the safety, effectiveness or quality of compounded drugs before they are marketed” (FDA, Compounding and the FDA: Questions and Answers). FDA says compounded drugs “should only be used in patients whose medical needs cannot be met by an FDA-approved drug,” and gives examples such as a patient allergic to a dye, or an elderly patient or a child who cannot swallow a tablet or capsule and needs a liquid (same source).

There are two kinds of compounders. Outsourcing facilities registered under section 503B are inspected by FDA on a risk-based schedule and must follow current good manufacturing practice. Drugs compounded in a state-licensed pharmacy under section 503A are not held to those manufacturing rules (FDA, Compounding Q&A). Neither kind makes the product FDA-approved.

Why does approval status matter?

Approval means FDA reviewed the specific product, in its specific form, for safety and effectiveness. The Orange Book is FDA’s list of drug products “approved on the basis of safety and effectiveness” (FDA, Orange Book). FDA does not verify the safety, effectiveness or quality of compounded drugs before they are marketed, and it warns that poor compounding can produce “a drug that contains too much or too little active ingredient,” as well as contamination (FDA, Compounding Q&A).

Form matters too, not just ingredient. The vardenafil ODT label shows that a dissolving tablet can deliver a different amount of drug than a swallowed tablet of the same medicine, and that water changes it again (vardenafil ODT label). An approved product comes with that kind of tested information. A compounded chewable or troche has no FDA-reviewed data on how much reaches the blood. Our guide to whether generic ED medications are safe covers the same approved-versus-unapproved line for ordinary tablets.

How can I check whether a product is FDA-approved?

Look the product up by name in FDA’s Drugs@FDA database or the Orange Book, which list approved products with their dosage form and whether they are marketed or discontinued (FDA, Orange Book). An approved product also has a full prescribing label on DailyMed with an NDA or ANDA number, like the vardenafil ODT and Vybrique labels cited here. If a seller or service cannot point to either, ask directly whether the product is compounded.

One label detail is worth knowing for the dissolving vardenafil tablet: it contains aspartame, a source of phenylalanine, which the label says “may be harmful” for people with phenylketonuria (vardenafil ODT label). Inactive ingredients can differ between forms of the same drug, so the full label is the place to check them.

When to talk to a clinician

Talk to the prescriber if swallowing tablets is hard for you, since FDA-approved dissolving forms exist for vardenafil and sildenafil and a clinician can say whether one suits your health and other medicines. The same conversation is the place to raise a heart condition, nitrate use, or phenylketonuria before starting any form. If a service offers a chewable, troche or gummy, it is fair to ask why an approved product would not meet your needs, which is the standard FDA itself describes for compounding (FDA, Compounding Q&A). For tadalafil specifically, our explainer on what tadalafil is covers its approved uses and label warnings.

Sources

• Vardenafil hydrochloride orally disintegrating tablets, prescribing information (Alembic, ANDA208324), DailyMed
• Vybrique (sildenafil) oral film, prescribing information (IBSA, NDA210858), DailyMed
• Drugs@FDA: Vybrique, NDA210858
• Drugs@FDA: Staxyn, NDA200179
• Drugs@FDA: Entadfi (finasteride and tadalafil) capsules, NDA215423
• Entadfi prescribing information, FDA
• Drugs@FDA: Chewtadzy, NDA218527
• Federal Register: Determination that Chewtadzy (tadalafil) chewable tablets were not withdrawn from sale for reasons of safety or effectiveness, April 16, 2026
• Tadliq (tadalafil) oral suspension, prescribing information, DailyMed
• Sildenafil for oral suspension, prescribing information (ANDA212260), DailyMed
• FDA: Compounding and the FDA: Questions and Answers
• FDA: Tainted honey-based products with hidden active drug ingredients
• FDA: Approved Drug Products with Therapeutic Equivalence Evaluations (Orange Book)